Brief: Encompass Health Q2 Adjusted EPS USD 1.11 Vs. IBES Estimate USD 1.01
05/08/2024 22:10
Aug 05 (Reuters) - Encompass Health Q2 adjusted EBITDA USD 271.8 million vs. IBES estimate USD 262.7 million. * Q2 adjusted free cash flow USD 142.5 million * Q2 operating revenue USD 1,301.2 million vs. IBES estimate USD 1,305 million
Recent news on Encompass Health
See all newsBrief: Encompass Health Issues Notice For Partial Redemption Of Its 4.500% Senior Notes Due 2028
Brief: Encompass Health Announces Pricing Of $500 Million Of Senior Notes Due 2034 In A Private Offering
Brief: Encompass Health Announces Private Offering Of Senior Notes
Brief: Encompass Health Announces Plans To Build A 50-Bed Inpatient Rehabilitation Hospital In Post Falls, Idaho
Brief: Encompass Health Declares Dividend On Common Stock